Vident Advisory’s Acadia Healthcare ACHC Stock Holding History

Vident Advisory’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,895	Closed	-$418K	–	1629
2025 Q3	$418K	Buy	+16,895	New	+$377K	﹤0.01%	1265

Other funds holding ACHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Vident Advisory's ACHC Position: Q4 2025 in Review

Vident Advisory sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 16,895 shares — an estimated $418K sold.

Vident Advisory first reported a position in ACHC in Q3 2025 and held it in 1 quarter. The position peaked at $418K in Q3 2025. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

Vident Advisory reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
Vident Advisory sold 16,895 Acadia Healthcare shares in Q4 2025, an estimated $418K.
Vident Advisory first reported a position in Acadia Healthcare in Q3 2025 and held it in 1 quarter.
Vident Advisory's Acadia Healthcare position peaked at $418K in Q3 2025.
254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.